Correlation of Disease Expression With Specific Genetic Mutations in Primary Hyperoxaluria

Location:

Rochester, Minn.

Trial status:

Open for Enrollment

Why is this study being done?

During your study visit, we will draw one tube, about two teaspoonfuls (1 to 1 ½ teaspoons for children), of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing. We will use the isolated DNA to try to identify the gene that is defective in Primary Hyperoxaluria by comparing it with the structure of genes in normal individuals, patients with Primary Hyperoxaluria, and family members of Primary Hyperoxaluria patients. In family members of primary hyperoxaluria patients, a 24 hour urine test may also be collected.

Who is eligible to participate?

Inclusion Criteria: - You have been diagnosed, or you are in the process of being diagnosed Primary Hyperoxaluria - You have a family member diagnosed with Primary Hyperoxaluria

What is involved?

During your study visit, we will draw two tubes, about four teaspoonfuls (3 teaspoons for children), of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing. We will use the isolated DNA to try to identify the gene that is defective in primary hyperoxaluria by comparing it with the structure of genes in normal individuals, patients with primary hyperoxaluria, and family members of primary hyperoxaluria patients. In family members of primary hyperoxaluria patients, a 24 hour urine test may also be collected.

How long is the study?

You will be in this study for only one visit.

Last updated:

12/20/2013

NCT ID:

NCT00589225

IRB Number:

434-03